ResMed Inc. (RMD) - NYSE
  • Mon, Feb. 22, 4:14 PM
    • ResMed (NYSE:RMD) acquires privately held Brighttree, a developer of business management and clinical cloud-based software applications for the post-acute care industry, for $800M in cash. ResMed will fund most of the purchase with debt.
    • The transaction will be immediately accretive to gross margins and non-GAAP EPS. It includes an estimated $300M from an anticipated future tax benefit, expected to positively affect ResMed's cash flow over 15 years.
    • Brightree booked $113M in sales and $43M in EBITDA last year.
    | Mon, Feb. 22, 4:14 PM | 2 Comments
Company Description
ResMed, Inc. designs, manufactures and markets medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. ResMed products include airflow generators, diagnostic products, mask systems, headgear and other accessories. The company was... More
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States